These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 12792926)

  • 1. A hybrid form of myeloid/NK-cell acute leukemia and myeloid/NK-cell precursor acute leukemia.
    Sun T; Pashaei S; Jaffrey I; Ryder J
    Hum Pathol; 2003 May; 34(5):504-8. PubMed ID: 12792926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignancies of natural killer (NK) cell precursor: myeloid/NK cell precursor acute leukemia and blastic NK cell lymphoma/leukemia.
    Suzuki R; Nakamura S
    Leuk Res; 1999 Jul; 23(7):615-24. PubMed ID: 10400182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural killer cell precursor acute lymphoma/leukemia presenting in an infant.
    Natkunam Y; Cherry AM; Cornbleet PJ
    Arch Pathol Lab Med; 2001 Mar; 125(3):413-8. PubMed ID: 11231495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blastic natural killer cell leukemia/lymphoma: a clinicopathologic study.
    DiGiuseppe JA; Louie DC; Williams JE; Miller DT; Griffin CA; Mann RB; Borowitz MJ
    Am J Surg Pathol; 1997 Oct; 21(10):1223-30. PubMed ID: 9331296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Killer T-cell induction in patients with blastic natural killer cell lymphoma/leukaemia: implications for successful treatment and possible therapeutic strategies.
    Yamada O; Ichikawa M; Okamoto T; Park C; Motoji T; Mizoguchi H; Shibuya A
    Br J Haematol; 2001 Apr; 113(1):153-60. PubMed ID: 11328295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uncommon cases of immature-type CD56+ natural killer (NK)-cell neoplasms, characterized by expression of myeloid antigen of blastic NK-cell lymphoma.
    Owatari S; Otsuka M; Takeshita T; Mizukami K; Suzuki S; Uozumi K; Tashiro Y; Arima N; Hanada S
    Int J Hematol; 2009 Mar; 89(2):188-194. PubMed ID: 19109730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD7+ and CD56+ myeloid/natural killer cell precursor acute leukemia: a distinct hematolymphoid disease entity.
    Suzuki R; Yamamoto K; Seto M; Kagami Y; Ogura M; Yatabe Y; Suchi T; Kodera Y; Morishima Y; Takahashi T; Saito H; Ueda R; Nakamura S
    Blood; 1997 Sep; 90(6):2417-28. PubMed ID: 9310493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
    Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
    Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blastic natural killer cell leukemia/lymphoma presenting as overt leukemia.
    Alvarez-Larrán A; Villamor N; Hernández-Boluda JC; Ferrer A; Camós M; Campo E; López-Guillermo A
    Clin Lymphoma; 2001 Dec; 2(3):178-82; discussion 183-4. PubMed ID: 11779295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flow cytometric immunophenotyping is of great value to diagnosis of natural killer cell neoplasms involving bone marrow and peripheral blood.
    Jiang NG; Jin YM; Niu Q; Zeng TT; Su J; Zhu HL
    Ann Hematol; 2013 Jan; 92(1):89-96. PubMed ID: 22992980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Five Chinese pediatric patients with leukemias possibly arising from immature natural killer cells: clinical features and courses.
    Guan XQ; Xu L; Ke ZY; Huang LB; Zhang XL; Zhang YC; Luo XQ
    Pediatr Hematol Oncol; 2011 Apr; 28(3):187-93. PubMed ID: 21271777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pediatric acute blastic natural killer cell leukemia.
    DuBois SG; Etzell JE; Matthay KK; Robbins E; Banerjee A
    Leuk Lymphoma; 2002 Apr; 43(4):901-6. PubMed ID: 12153184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pediatric myeloid/NK cell precursor lymphoma/leukemia expressing T/NK immunophenotype markers.
    Hashii Y; Okuda T; Ohta H; Ozono K; Hara J
    Int J Hematol; 2010 Apr; 91(3):525-9. PubMed ID: 20146030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myeloid/NK cell acute leukemia.
    Chen B; Xu X; Ji M; Lin G
    Int J Hematol; 2009 Apr; 89(3):365-367. PubMed ID: 19326059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myeloid/natural killer cell precursor acute leukemia with tetraploidy.
    Dinçol G; Palandüz S; Nalçaci M; Uçur A; Büyükaydin B
    Cancer Genet Cytogenet; 2005 Dec; 163(2):156-9. PubMed ID: 16337859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blastic natural killer (NK) cell leukemia (agranular CD4+CD56+ leukemia).
    Zhang K; Prichard JW; Brown RE
    Ann Clin Lab Sci; 2006; 36(2):212-5. PubMed ID: 16682521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD56+/CD4+ lymphomas and leukemias are morphologically, immunophenotypically, cytogenetically, and clinically diverse.
    Rakozy CK; Mohamed AN; Vo TD; Khatib G; Long PM; Eilender D; Palutke M
    Am J Clin Pathol; 2001 Aug; 116(2):168-76. PubMed ID: 11488062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extramedullary presentation of acute leukaemia: a case of myeloid/natural killer cell precursor leukaemia.
    Chen VM; McIlroy K; Loui JP; Fay K; Ward C
    Pathology; 2003 Aug; 35(4):325-9. PubMed ID: 12959763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blastic natural killer cell lymphoma arising from the mediastinum with terminal deoxynucleotidyl transferase expression.
    Isobe K; Tamaru JI; Nakamura S; Itami J; Aruga T; Uno T; Yasuda S; Mikata A; Ito H
    Pathol Int; 2001 Jan; 51(1):55-9. PubMed ID: 11148466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress in understanding and managing natural killer-cell malignancies.
    Oshimi K
    Br J Haematol; 2007 Nov; 139(4):532-44. PubMed ID: 17916099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.